Brazil OKs fast-track assessment for device and pharma trial applications
This article was originally published in SRA
Executive Summary
Brazil's regulatory agency, Anvisa, has announced that proposals to fast-track the licensing-assessment of a large proportion of applications for clinical trials of drugs and medical devices have received approved1.